Abstract
The epidemic of obesity has become a major public health problem. Common-form obesity is underpinned by both environmental and genetic factors. Epidemiological studies have documented that increased intakes of energy and reduced consumption of high-fiber foods, as well as sedentary lifestyle, were among the major driving forces for the epidemic of obesity. Recent genome-wide association studies have identified several genes convincingly related to obesity risk, including the fat mass and obesity associated gene and the melanocortin-4 receptor gene. Testing gene-environment interaction is a relatively new field. This article reviews recent advances in identifying the genetic and environmental risk factors (lifestyle and diet) for obesity. The evidence for gene-environment interaction, especially from observational studies and randomized intervention trials, is examined specifically. Knowledge about the interplay between genetic and environmental components may facilitate the choice of more effective and specific measures for obesity prevention based on the personalized genetic make-up.
Keywords: environment, gene, interaction, obesity
INTRODUCTION
The prevalence of obesity has been increasing at an alarming rate worldwide during past decades.1 Accordingly, the World Health Organization has described obesity as a “global epidemic”. In the United States, it is estimated that >60% of adults are either obese or overweight. The number of children and adolescents who are considered overweight (i.e., ≥95th percentile) or at risk for overweight (i.e., ≥85th percentile) has increased similarly.2 Obesity is usually associated with many metabolic abnormalities including dyslipidemia, insulin resistance and hyperglycemia, and increased risk of coronary heart disease, type 2 diabetes, asthma, sleep apnea, hypertension, certain cancers, and all-cause mortality.3,4
Classic genetic analyses performed in families, adoptees, and twins have clearly shown there is a genetic contribution to obesity.5–7 A popular conception regarding the genetic makeup of complex diseases, including obesity, is the “common disease/common variant” (CD/ CV) hypothesis.8 According to this theory, common disorders are governed by common genetic variants that do not conform to Mendelian patterns of inheritance in their effects. The recent advance in genome-wide association (GWA) mapping holds tremendous potential for contributing to the identification of human obesity genes and provides deeper insight into the genetic effects on obesity development. Several genes such as FTO (fat mass and obesity associated) and MC4R (melanocortin-4 receptor) identified by GWA scans have been convincingly associated with obesity risk in various populations.9–13 Of note, the phenotypic variance accounted for by an individual genetic variant is essentially minor. These findings indicate that large-scale population sets are needed to identify the small genetic effects, particularly for the variants with low frequency. Thus, it is not surprising that replication of genetic association may fail in some small samples or in subjects exposed to other environmental factors.
Obesity is a multifactorial abnormality that has a genetic basis but requires environmental influences to manifest. Numerous epidemiological studies and clinical trials have examined the roles of lifestyle (e.g., physical inactivity) and dietary factors (e.g., fat, carbohydrates, protein, and minerals) in obesity prevention and weight control. In the past decade, the body of studies on gene-environment interactions has also grown rapidly. This review summarizes recent advances in identifying the genetic and environmental factors (with a focus on lifestyle and diet) related to obesity, and examines the published empirical evidence for gene-environment interactions associated with obesity risk.
FROM LINKAGE SCAN TO GENOME-WIDE ASSOCIATION MAPPING
Familial aggregation is a prominent characteristic of monogenic-form obesity but is less evident for common-form obesity.14 An appreciation of the genetic contribution to common-form obesity is a relatively recent development. The fraction of the population variation explained by genetic factors (heritability) has been considered in a large number of twin, adoption, and family studies. In general, ∼40–60% of the variation in obesity-related phenotypes, such as body mass index (BMI), sum of skinfold thickness, fat mass, and leptin levels, has been estimated to be heritable.15 The past decade witnessed tremendous efforts to find the specific loci or genes for obesity, primarily through the combination of linkage scan and candidate gene-based association studies. Linkage analysis is performed to identify the disease loci by examining the cosegregation of genetic markers distributed evenly throughout the genome with the disease within families.As summarized in the latest version of the Human Obesity Gene Map, there are 253 quantitative-trait loci (QTLs) identified in 61 genome-wide scans, and 52 genomic regions contain QTLs supported by two or more studies.16 While linkage analysis is massively successful in identifying mutations underlying the rare Mendelian disorders, it does have shortcomings and the identification of variants for common-form obesity has met with limited and uneven success through this approach.
The candidate-gene association analyses focus on loci identified functionally (experimental evidence) or positionally (linkage evidence).17 To date, 127 different candidate genes have been associated with obesity-related phenotypes.14,16 Of note, the vast majority of the candidates are selected because of their known or hypothesized role in the development of obesity such as adipogenesis, lipid turnover, insulin signaling, mitochondrion and energy expenditure, and adipokine secretion.18 Few genes are chosen from areas containing pure linkage signals.An example of linkage mapping-based success is the recent identification of PCSK1 (prohormone convertase 1/3) gene variants conferring obesity risk. In this study, Benzinou et al.19 sequenced the candidate gene PCSK1 located in a 5.6-Mb interval on chromosome 5q linked with obesity-associated traits and found 19 common SNPs. In a total of 13,659 individuals of European ancestry, variants rs6232 and rs6234-rs6235 pair were consistently associated with obesity in adults and children (P = 7.27 × 10−8 and P = 2.31 × 10−12,respectively).Significant associations of biologically relevant genes such as PPARG (peroxisome proliferators-activated receptor gamma), UCP1 (uncoupling protein 1), UCP2, UCP3, ADRB2 (beta-adrenergic receptor 2), ADRB3, and PLIN (perilipin) have been observed in at least five human studies. Most genetic associations, however, are difficult to replicate. Several factors may account for the low reproducibility in associations: inadequate sample sizes for modest effect, inadequate capture of the genetic variation, varying criteria for selection of candidates, and genuine heterogeneity in genetic effects. It was estimated that 20 to 30% of genetic associations were real and had modest effects, while false-positive associations were abundant in the literature.20 Large-scale meta-analysis may lessen the influence of both false-positive and false-negative findings and facilitate the derivation of more reliable associations.21,22
Most candidate-gene association studies focus on only a limited number of single nucleotide polymorphisms (SNPs). The narrow scope in surveying for the variation in the whole genome substantially hampers the success of the candidate-gene approach. Identification of susceptibility genes for obesity on the whole-genome scale has been enhanced by recent advances in genotyping technology along with the HapMap initiative, which has increased collection of variation information in the human genome. In the first GWA study on obesity, Herbert et al.23 genotyped 116,204 SNPs among 694 individuals from the Framingham Heart Study offspring cohort. A common SNP, rs7566605 (G > C; MAF = 20%) near the insulin-induced gene 2 (INSIG2), was significantly associated with childhood and adulthood obesity risk. The CC genotype was related to 22% increased risk of obesity. However, several later studies generated highly mixed results.24,25 In 2007, the Welcome Trust Case-Control Consortium (WTCCC) reported that the common variant rs9939609 (T > A; MAF = 30%) was significantly associated with obesity risk. In the replication samples of 38,759 European participants, the AA genotype was related to 1 kg/m2 higher BMI, 2.3 kg higher body weight, and 67% increased risk of obesity compared to the TT genotype.10 This finding was replicated in most additional studies, although the data are not entirely consistent ,especially in some ethnic groups.11,26–28 In a recent analysis combining several GWA scans, Loos et al.29 found significant associations between SNP rs17782313, which is mapped 188kb downstream of a biological candidate gene MC4R for monogenic obesity, and fat mass and obesity risk: the per-minor allele increase in BMI was 0.49 kg/m2. This study demonstrates that the different forms of variants (rare vs. common) in some genes may cause either monogenic or common-form obesity that shares the same phathophysiological changes.
LIFESTYLE AND DIETARY RISK FACTORS FOR OBESITY
Weight gain and obesity in free-living populations result from a long-term positive energy balance, i.e., the amount of energy consumed is greater than the amount of energy spent. A wealth of evidence points to many dietary and lifestyle factors that can directly or indirectly tip the balance of energy input and output. The contributions of environmental factors to obesity have been the focus of many research initiatives. Recently, Papas et al.30 performed a meta-analysis on the relationship between obesity and the built environment, which largely determines the availability and convenience of options for physical activity and food acquisition. The authors found statistically significant relationships between some aspects of the built environment and risk of obesity in 17 of 20 studies.
Increasing energy intake is a major contributor to the current obesity epidemic. The past several decades have witnessed a marked increase in the total amount of energy intake, especially in populations with rising rates of obesity. For example, data from the National Health and Nutrition Examination Survey (NHANES) showed that energy intake increased from an average of 2450 kcal/day in 1971–1974 to 2618 kcal/day in 1999–2000, an increase of 168 kcal/day or 7%, among men in the United States. The upward shift was greater among women, increasing by 335 kcal/day or 22%.31 Because of the high energy density of fat and the enhanced palatability of high-fat foods, it was widely believed that high intakes of dietary fat contributed to the greater weight gain.32 However, epidemiological studies and clinical trials have generated data that is quite mixed and there are diverse opinions about whether or not the percentage of dietary fat plays an important role in the rising prevalence of obesity.33 In the last half century, there has been a sudden upsurge in consumption of carbohydrates (CHOs) as the major component of the diet, and carbohydrates are now being eaten in a more refined form.34 Few epidemiological studies have directly assessed the relationship between CHOs and obesity, while some evidence from short-term intervention trials indicate that CHO restriction may moderately promote weight loss.35 The proportion of CHO in the diet tends to vary reciprocally with fat.36 Therefore, it is difficult to segregate the impact of the total amount of CHO in the diet from total fat. Many studies have shown that diets rich in whole grains and fiber were inversely related to BMI and weight gain,37,38 which is likely due to the incomplete digestion and absorption and increased satiety caused by delayed gastric emptying and subsequent gastric distention. In addition, other foods/nutrients such as nuts, fruits and vegetables, dairy products, coffee, and calcium were also associated with body fatness in some but not all studies.39–42 The inconsistency in these observations is partly due to the complexity of confounding by other sociodemographic and lifestyle variables.
The adverse effect of unhealthy dietary habit (e.g., more consumption of refined CHOs; reduced intake of fiber, vegetables, and fruit; and overeating) on obesity can be exacerbated by the lack of physical activity that results from the popularization of television and computers and the increasing use of labor-saving transportation devices. Some large studies have shown that the risk of significant weight gain is greater in individuals who were sedentary than in those who were more active. For example, Williamson et al.,43 investigating the effects of self-reported recreational physical activity (low, medium, high) on 10-year weight change in 3515 men and 5810 women, found that the relative risks for gaining >13 kg in individuals whose activity level was low compared with those in the high-activity level were 2.3 in men and 7.1 in women. Similarly, in a study of 12,699 adult Finns, Russanen et al.,44 found that people who rarely engaged in leisure-time physical activity were 1.6 (men) and 1.9 (women) times as likely to gain 5 kg in 5 years as those who frequently engaged in such activity. Schoeller45 reviewed cross-sectional data from double-labeled water studies and longitudinal studies: The data similarly indicate that the prevalence of overweight, BMI, or body fat increases along with decreasing physical activity. The role of sedentary behavior as a contributor to the obesity epidemic has also been evaluated in children and adolescents. Although television-watching and physical inactivity have been related to obesity,46 the increase in adiposity may be due to snacking that occurs during TV viewing.
GENE-ENVIRONMENT INTERACTION: PHENOMENA AND TESTING
The recent epidemic of obesity along with the increasing spread of Western-type lifestyles worldwide is a good illustration of the concept of gene-environment interaction. Because the gene pool of a certain population has been relatively constant for many generations, it seems that dramatic changes in lifestyle and dietary habits have played a role in triggering the recent surge of excessive adiposity. The question is why are humans living in a modern social environment so susceptible to obesity? A widely held hypothesis is that the evolutionary process generates this genetic predisposition.47 The first exposition of this idea was by Neel,48 who suggested that obesity and diabetes stemmed from natural selection of our ancient ancestors favoring a “thrifty” genotype that enabled highly efficient storage of fat during periods of food deficiency. Famine has been a common feature of human history, stretching back to the earliest part of the Paleolithic period 50,000 years ago.49,50 Compared with lean individuals, those who had more body fat more likely carried certain genetic information that favored more efficient storage of energy; they were, therefore, more likely to survive periods of famine. In addition, lean people were more likely to succumb to various conditions such as infectious disease. Thus, the ability to conserve calories by storing more fat offers a genetic advantage for selection of this genotype during periods of food scarcity. When individuals are faced with higher caloric loads in a modern context, however, carrying the thrifty genotype becomes a risk factor for obesity and related metabolic disorders. This may well be the case for genes such as PPARG, FTO, and MC4R that are linked with obesity and diabetes.10,29,51
Urbanization and migration have provided good experimental settings for testing the interactive relationship between genetic background and changes in lifestyle and dietary patterns. Risk of obesity increases after migration from poor to affluent countries.52 The adoption of a Western dietary pattern is believed to be the major cause of the obesity prevalent in immigrants.53 The children of immigrants may fare even worse. In the United States, Asian American and Hispanic American adolescents are more than twice as likely to be obese as first-generation immigrants from their countries of origin.54
These observations support a model in which susceptibility to obesity is determined largely by genetic factors, but the environment prompts phenotypic expression. The concept that “nurture” operates on an underlying pool of genes that contribute to obesity susceptibility has important implications for our approach to the prevention and treatment of obesity. The causal web of obesity is complex, and it is a significant challenge to uncover the intricate pattern of interlinking threads. Recent advances in genetic mapping for complex diseases make it feasible to systematically evaluate nature-nurture interactions at the molecular level. Conceptually, gene-environment interaction occurs when the effect of one factor on a person’s health is conditional on the other. In recent years, an epidemiologic framework for evaluating gene-environment interaction has been proposed.55 Statistically significant interaction can be detected in different ways. The most common approach is to test departure from the multiplicative model of interaction, i.e., to test whether the relative risk for joint exposure is statistically significantly greater or smaller than what would be expected by multiplying the relative risk for environmental exposure alone and for the genetic susceptibility alone. Alternatively, the interactions of the genotype and environmental factors can be measured as a departure from an additive model of disease risk.56 The appropriate scale of interaction testing that may reflect biological interaction has been a controversial topic, as some argue that the assessment of interaction on an additive scale is more indicative of the underlying causal mechanism.
OBSERVATIONAL EVIDENCE
When information on both environmental exposures (lifestyle and dietary intake) and genotyping is collected, the gene-environment interactions can be tested by the observational studies. Cross-sectional and retrospective case-control designs are most often used for studying gene-environment interactions in relation to continuous differences in obesity-related traits and dichotomous obesity status. A case-only design has also been employed for examining multiplicative gene-environment interactions, assuming the environment factors and genotypes are independent.57 As a limitation, a case-only study cannot detect the main effects of exposure variables. Although such studies are relatively easy to conduct, they are susceptible to the influence of selection, recall (e.g., diet and lifestyle), and survival bias. Prospective cohort studies collect information on environmental exposure before the occurrence of disease and hold an advantage in minimizing these biases.58 Most studies focus on “candidate genes”, especially those related to appetite control, food intake, energy balance, and adipose metabolism (Table 1).Among environmental factors, physical inactivity, total energy intake, and consumption of various dietary fats (total fat, saturated fat acid [SFA], polyunsaturated fat acid [PUFA]) and CHOs (including fibers) have attracted a great deal of attention. Gene-environment interactions can be assessed at single SNP and haplotype (the combination of SNPs) levels. Due to statistical and computational difficulty, the test on gene-environment interaction has not yet been practical on a whole-genome scale.
Table 1.
Reference | Subjects* | Gene (variants) |
Lifestyle factors |
Major findings |
---|---|---|---|---|
Meirhaeghe et al. (1999)68 |
1152 | ADRB2 (Gln27Glu) |
Physical activity |
Men carrying Gln27Gln genotype had increased risk of adiposity only with no physical activity. No interaction was observed in women |
Luan et al. (2001)64 |
592 |
PPARG (Pro12Ala) |
Total fat, P:S ratio |
BMI was higher among Ala allele carriers only when the P:S ratio was low, and the opposite was seen when P:S ratio was high (p-interaction = 0.0039) |
Corbalan et al. (2002)69 |
252 F | ADRB2 (Gln27Glu) |
Physical activity |
In women who were more active, Glu-allele carriers had higher BMI than non-carriers. |
Marti et al. (2002)67 |
313 |
PPARG (Pro12Ala) |
CHO | Pro12Ala was associated with increased risk of obesity only in those with higher CHO intake (p-interaction = 0.02) |
Martinez et al. (2003)66 |
313 |
ADRB2 (Gln27Glu) |
CHO | Women with high CHO intake had greater risk of obesity than those with low CHO intake only in Gln27Glu heterozygotes (p-interaction = 0.058) |
Nieters et al. (2002)62 |
306 | 11 genes (15 SNPs) |
n-6 PUFA | Substantial interaction between variants in PPARG2, TNFA, leptin (possibly APM1, HSL) and dietary n-6 FA intake in relation to obesity risk |
Robitaille et al. (2003)65 |
313 M/407 F |
PPARG (Pro12Ala) |
Total fat, SFA | In women, Pro12Pro homozygotes were positively associated with total fat and SFA intake in relation to WC and BMI, but not in Ala-allele carriers |
Memisoglu et al. (2003)63 |
2142 F |
PPARG (Pro12Ala) |
Total fat, fatty acids, P:S ratio |
BMI was positively related to total fat only in Pro12Pro homozygotes (p-interaction = 0.0003); BMI was negatively related to MUFA only in Ala-allele carriers (p-interaction = 0.003) |
Robitaille et al. (2004)61 |
632 M |
PPARA (Leu162Val) |
Total fat, SFA | Total fat and saturated fat intake were positively related to WC only in Leu162Leu homozygotes (p-interaction = 0.01 and 0.008, respectively) |
Alonso et al. (2005)72 |
300 | UCP3 (−55C > T) |
Physical activity |
Carrying T-allele was associated with lower risk of obesity only in those with higher physical activity |
Berentzen et al. (2005)73 |
1285 | UCP2 (ID), UCP3 (−55C > T) |
Physical activity |
No interaction in relation to 10-year weight change |
Miyaki et al. (2005)59 |
295 M |
ADRB3 (Trp64Arg) |
Total energy | Arg64-allele carriers were associated with greater obesity risk than Trp64Trp homozygotes, but only in the highest energy intake quartile |
Moran et al. (2005)70 |
1016 | ACE (I/D) | Physical activity | Carrying D-allele was associated with increased fat thickness; this association was strongest in women with no extra exercise |
Ridderstrale et al. (2006)71 |
902 M/899 F | PPARGC1A (GLy482Ser) |
Physical activity |
Elderly men carrying Ser-allele had increased risk of obesity |
Song et al. (2007)60 |
285 M |
IL6R (Asp358Ala) |
Total energy | Energy intake was significantly associated with WC in T-allele carriers, but not in GG homozygotes (p-interaction = 0.03) |
Andeasen et al. (2008)28 |
17,162 | FTO (rs9939609) |
Physical activity |
Physically inactive AA homozygotes had an increase in BMI compared with TT homozygotes (p-interaction = 0.007) |
If not indicated, the studies include both male (M) and female (F).
Abbreviations: BMI, body mass index; CHO, carbohydrates; MUFA, monounsaturated fatty acid; P:S ratio, ratio of polyunsaturated fat to saturated fat; PUFA, polyunsaturated fatty acid; SFA, saturated fatty acid; WC, waist circumstance.
Several studies specifically examined the interactions between energy intake and genes involved in the regulation of energy balance and adipose tissue metabolism. Miyaki et al.59 found that high energy intake interacted with the Trp64 Arg polymorphism of ADRB3 gene and led to a significant increase in risk of obesity. In a recent study of 285 healthy Japanese men, Song et al.60 found that a missense variant in the IL6R (interleukin 6 receptor) gene, Asp358Ala (T > G substitution) interacted significantly with dietary energy intake levels in relation to the risk of abdominal obesity (P for interaction = 0.03). There was significant association between waist circumference and dietary energy intake in individuals with the TT + GT genotypes (P = 0.048), but not in subjects with the GG genotype. Because of their high energy intensity, dietary fats have been a focus of attention relative to their interactions with genetic components in determining obesity risk. In a cross-sectional study of 632 men, Robitaille et al.61 found that intake of total fat and SFA was significantly associated with waist circumference in individuals carrying the PPARA Leu162/Leu162 genotype, but not in those with the Val162 allele (P-interaction = 0.01 between fat intake and waist circumference: P-interaction = 0.008 between SFA intake and waist circumference). In a case-control study of 154 obese subjects (BMI > 35 kg/m2) and 154 age- and sex-matched normal-weight controls, Nieters et al.62 reported possible interactions between dietary fatty acids and genes including LEP (−2548 G/A; P = 0.045 for linoleic acid), TNF (−307G/A; P = 0.142 for linoleic acid; P = 0.095 for arachidonic acid), and PPARG2 (Pro12Ala; P = 0.166 for linoleic acid; P = 0.080 for arachidonic acid). In the Nurses’ Health Study, it was found that women in the highest quintile of total fat intake had significantly higher mean BMI than those in the lowest quintile (27.3 vs. 25.4 kg/m2; P < 0.0001) if they carried the PPARG Pro/ Pro genotype. No significant trend was observed between dietary fat intake and BMI among women carrying the 12Ala variant (P-interaction = 0.003).63 Dietary fat-PPARG interactions were also observed in other studies.64,65
A few studies tested the interaction between genetic variants and intake of CHOs (Table 1). In a case-control study with 154 obese subjects (BMI > 30 kg/m2) and 154 lean controls (BMI < 25 kg/m2) (∼80% women), Martinez et al.66 found that, in women carrying the ADRB2 Gln27Glu genotype, higher intake of CHO (>49% of energy) was associated with 2.56 times greater obesity risk than in those with lower intake. Among women with the wild-type homozygotes, CHO intake was associated with reduced obesity risk, although the association was not statistically significant. The test for interaction was only marginally significant (P = 0.058). Similarly, a higher CHO/fat ratio (>1.77) was significantly associated with 3.21 times higher obesity risk only in women carrying the Gln27Glu genotype. In the same study sample, a significant interaction (P = 0.02) was also observed between CHO intake and the Pro12Ala polymorphism of the PPARG gene in relation to BMI. Individuals with the Pro12Ala genotype had higher BMI than those with the Pro12Pro genotype (35.1 vs. 32.4 kg/m2) when their CHO intake was above the median (49% of energy). The opposite association (31.5 vs. 33.4 kg/m2) was observed in those who had lower CHO intakes.67
In addition to the dietary components, several studies have documented potential interaction between physical activity and genetic variants (Table 1). Meirhaeghe et al.68 found a significant interaction between the Gln27Glu polymorphism and physical activity in relation to body weight (P = 0.009), BMI (P = 0.007), and waist (P = 0.03) and hip (P = 0.01) circumference in men. The Gln homozygotes had significantly higher adiposity measures than the Glu-allele carriers only in men who did not engage in physical activity; the gene-physical activity interaction was not observed in women. Another study,69 however, reported a significant interaction between this genetic variant and physical activity in women. Among those who were physically active, Glu-allele carriers had higher BMI than non-carriers. In a cross-sectional study with 1016 teen-aged Greeks, Moran et al.70 reported that carrying the D allele in the AGE gene was associated with increased adipose tissue thickness. This association was strongest in women who participated in no extra exercise and accounted for 6.5% of the phenotypic variance in adipose tissue thickness. In a population-based study of 899 women and 902 men aged 30 and 75 years, Ridderstrale et al.71 reported that carrying Gly482Ser of the PPARGC1A gene was associated with increased risk of obesity only in elderly men (age ≥ 50) with low physical activity. Some other studies suggested that the genetic variants in UCP2 and UCP3 genes might also modulate the effects of physical activity on obesity risk72,73 Recently, Andreasen et al.28 reported a significant interaction between the FTO gene variant rs9939609 and physical activity in relation to obesity risk in a Danish population. Significant differences in BMI between the AA and TT genotypes were observed only among physically inactive subjects. The results suggest that higher physical activity may attenuate the adverse effects of the FTO variant on obesity.
GENETIC MODIFICATION ON DIET/LIFESTYLE INTERVENTION AND WEIGHT LOSS AND MAINTENANCE
Although observational studies are relatively easy to conduct, the results obtained from them are at most suggestive, as various sources of bias (selection, survival, and recall bias) may lead to spurious results and statistical significance does not necessarily imply causality. More reliable evidence for interactions between the genetic components and diet/lifestyle factors can be derived from randomized clinical trials. In contrast to observational studies, the study conditions in randomized clinical trials are controlled directly by the investigators, including the specifically defined dietary intakes and physical activity. This control minimizes the possibility of bias and increases the level of causality. In principle, the best-powered design is to examine the intervention of monitored changes in diet/lifestyle among subjects with predetermined genotypes, matched for potential confounders. However, this is not an efficient approach considering the increasingly expanding list of susceptibility genes to be tested. In fact, most studies genotype candidate genes in existing trials testing the effects of various diet/lifestyle interventions on weight changes and maintenance (Table 2).
Table 2.
Reference | Subjects* | Gene (Variants) | Intervention | Major findings |
---|---|---|---|---|
Yoshida et al. (1995)75 |
88 F | ADRB3 (Trp64Arg) | LCD + exercise, 3 mo |
Arg64-allele carriers lost less weight than Trp64Trp homozygotes (P < 0.05) |
Fumeron et al. (1996)81 |
163 |
UCP1 (BclI A > G [3826]), ADRB3 (Trp64Arg) |
LCD, 2.5 mo |
UCP1 G-allele carriers lost less weight (P < 0.05) than AA homozygotes |
Sakane et al. (1997)76 |
61 F |
ADRB3 (Trp64Arg) |
LCD + exercise, 3 mo |
Arg64-allele carriers had smaller decreases in weight and WHR than Trp64Trp homozygotes |
Kogure et al. (1998)82 |
113 F |
UCP1 (−3826 A > G), ADRB3 (Trp64Arg) |
LCD + exercise, 3 mo |
UCP1 GG homozygotes lost less weight than A-allele carriers (P < 0.05); ADRB3 Arg64-allele carriers lost less weight than Trp64Trp homozygotes; Those carrying both variants had less weight loss than those carrying either genotype alone. |
Mammes et al. (1998)84 |
38 M/79 F | LEP (8 SNPs) | LCD, 2.5 mo | In women, the SNP −2549C allele was associated with lower BMI loss (P = 0.05) after intervention |
Mammes et al. (2001)85 |
114 F/65 M | LEPR (T343C) | LCD, 2.5 mo | Women carrying C- allele lost more weight than TT homozygotes (P = 0.006) |
Xinli et al. (2001)83 |
31 M/16 F |
ADRB3 (Trp64Arg) |
Low cholesterol and SFA based on NCEPA step1 diet, 3 mo |
Increases in weight and BMI were lower in children with Trp64Trp homozygotes than in the Arg64-carriers and the control group (P < 0.05) |
Rawson et al. (2002)77 |
34 F |
ADRB3 (Trp64Arg) |
AHA step2 diet (1200 kcal/d), 13.5 ± 2.6 mo |
No interaction in relation to body composition and total daily energy expenditure |
Shiwaku et al. (2003)74 |
76 F |
ADRB3 (Trp64Arg) |
LCD + exercise, 3 mo |
Arg64-allele carriers lost less weight than Trp64Trp homozygotes (P = 0.035) |
Aberle et al. (2005)86 |
606 M |
APOA5 (−1131T > C) |
Low fat, 3 mo | C-allele carriers lost more weight than TT homozygotes (P = 0.002) |
Corella et al. (2005)87 |
9 M/39 F |
PLIN (11482G > A) |
LCD, 1 y | GG homozygotes lost more weight than A-allele carriers (P = 0.02) |
Shin et al. (2005)79 |
296 F |
UCP1 (A3826G, A1766G, Ala64Thr) |
VLCD, 1 mo | The common haplotype [GAG] was associated with less reduction of WHR (P = 0.006) and body fat mass (P = 0.05) than in non-carriers |
Cha et al. (2006)78 |
214 F | UCP3 (6 SNPs) | VLCD, 1 mo | The common haplotype [CGTACC] was associated with an increased reduction in body weight (P = 0.016) and BMI (P = 0.039); Int3-47G > A G-carriers lost more weight than AA homozygotes (P = 0.02) |
De Luis et al. (2006)88 |
14 M/55 F |
FABP2 (Ala54Thr) |
LCD + exercise, 3 mo |
Thr-allele carriers had greater decrease in fat mass than Ala54Ala homozygotes (P < 0.05) |
Goyenechea et al. (2006)89 |
22 M/55 F |
IL6 (−174G > C), P PARG (Pro12Ala) |
LCD, 2.5 mo |
IL6 C-allele carriers had less weight regain after 1-y weight-loss program (P = 0.049); carriers of both variants maintained the weight loss better (P = 0.043) than non-carriers |
Santoro et al. (2007)90 |
107 M/77 F |
MC3R (C17A, G241A) |
LCD + exercise, 2 mo |
Wild-type homozygotes lost more weight than rare-allele carriers (P = 0.03) after 12 mo |
Yoon et al. (2007)80 |
301 F |
UCP2 (4 SNPs), UCP3 (10 SNPs) |
VLCD, 1 mo | UCP2 −866G > A and the major haplotype [GGCdelCGTACC] had a significant reduction in fat mass (P = 0.002 and 0.004) |
If not indicated, the studies include both male (M) and female (F).
Abbreviations: BMI, body mass index; LCD, low-calorie diet; VLCD, very-low-calorie diet; WHR, waist-to-hip ratio.
Many studies have examined the modification effects of the key genes regulating energy balance on weight loss intervention. Shiwaku et al.74 investigated 76 healthy perimenopausal Japanese women (age 54.7 years; BMI 21–33 kg/m2) in a behavioral weight-loss program with a 10% low-calorie diet (LCD) and exercise (over 7000 steps/day) regimen. The intervention induced a significant difference in weight loss (−0.74 vs.−0.01 kg) between women with the wild-type genotype and those with a Trp64Arg variant in the ADRB3 gene.74 Similarly, several other studies also showed that carriers of ADRB3 64Arg allele might lose less weight than the Trp64Trp homozygotes in response to the LCD intervention.75,76 However, in another weight-loss intervention study (American Heart Association step2 diet) of 34 obese (BMI ≥ 27 kg/m2), postmenopausal, Caucasian women (19 carriers and 15 non-carriers for the Trp64Arg variant), no effect of the Trp64Arg variant was found on weight loss, body composition (BMI, percent body fat, fat-free mass, fat mass), and energy expenditure.77 Korean researchers conducted a 1-month weight control program with a very-low-calorie diet (VLCD; 700 kcal/day) in 453 overweight Korean female subjects (BMI > 25 kg/m2). In a series of analyses among women who finished the intervention (n = 214, 296, and 301), SNPs/haplotypes in the uncoupling protein gene family (UCP1, 2, and 3) were significantly associated with an increased reduction in body weight, body fat mass, and waist-to-hip ratio.78–80 The modification of variants in the UCP gene family on weight change in response to LCD intervention was also observed in other studies.81,82
Similar genetic modification effects on dietary intervention were also observed in children. Xinli et al.83 examined the effect of the Trp64Arp polymorphism in ADRB3 on obesity after 3 months of dietary intervention (a diet low in cholesterol and SFA, based on the step1 diet of the National Cholesterol Education Program of America) in 47 obese Chinese children. The increases in weight and BMI were significantly lower in obese children without the variant than in the control group. Changes in weight and BMI in obese children with the variant were similar to the results in the controls.
Some other genetic variants were also found to modulate the effects of dietary intervention on weight loss. Mammes et al.84,85 examined the variants in LEP and LEPR genes in modifying the response to LCD intervention. In one analysis including 117 obese patients (79 women and 38 men; mean age 42 years; mean BMI 33.2 kg/m2) who were prescribed a LCD with a 25% reduction in their spontaneous energy intake for 2.5 months, a SNP −2549C > A (MAF = 0.44) near to 5′ region of LEP gene was significantly related to lower BMI loss (P = 0.05).84 In their later study of an expanded sample of 179 patients (114 women and 65 men; BMI ≥ 27 kg/m2), they found that women carrying the C allele of Ser (T) 343 Ser (C) variant of LEPR gene lost more weight in response to LCD than the non-carriers (P = 0.006).85 In another study, 606 hyperlipemic and overweight men were instructed to reduce their daily intake of fat to a maximum of 45–50 g. Patient compliance was supervised by means of a nutritional diary that was reviewed at follow-up visits at 6 weeks and 3 months. The reduction of BMI was significantly higher in carriers of the C allele of the −1131T > C polymorphism in APOA5 (apolipoprotein A5) gene compared with the non-carriers (P = 0.0021).86 The common variants in genes such as PLIN, IL6, PPARG, FABP2 (fatty acid binding protein 2), and MC3R (melanocortin-3 receptor) were also found to modulate the intervention (LCD or LCD and exercise) on weight loss (Table 2).87–90
CONCLUSION
Recent changes in the availability and cost of palatable energy-dense food and the reduction in physical activity during work and recreation on the background of evolutionarily engraved response patterns (genetic predisposition) have undoubtedly contributed to the current obesity epidemic. Evidence from association studies and intervention trials continues to mount, indicating that genetic components may modify lifestyle effects on the development of obesity. However, these findings are at most preliminary. Various sources of bias may lead to spurious interactions in observational studies, especially cross-sectional and retrospective studies. A randomized clinical trial is an excellent model for testing gene-lifestyle interactions. However, since most interventions combine changes in diet, weight loss, and physical activity, it is difficult to tease out the interactive effect attributable to any specific component. In addition, most intervention trials are small and short-term, thus limiting the statistical power and the ability to identify moderate interactions and long-term genetic effects. Therefore, a large-scale, prospective study with detailed information for lifestyle and dietary intake would be an ideal model for identifying gene-environment interactions.
DNA sequencing alone does not provide enough information to determine the molecular pathways of an organism in healthy and diseased states. This understanding has helped spawn numerous multidisciplinary approaches to the study of complexity in human health. Increasing research effort is now invested in post-genomic science, particularly in the related disciplines of transcriptomics, proteomics, and metabolomics. One such effort is the field of nutrigenomics,91,92 a new form of nutrition science targeting the detection of multilayer interactions among food/nutrients and genes, proteins, and metabolites. There is a strong demand for technological solutions that will help to integrate the various “omics” information with our traditional knowledge of nutrition.
Population-wide prevention and treatment efforts aimed at reducing obesity are usually costly and difficult to conduct. Therefore, efforts to prevent obesity at the public health level can be focused on identification and counseling of susceptible individuals. This situation emphasizes the need for greater understanding of the ways in which interactions between diet/lifestyle and genes may help distinguish who will and who will not respond to dietary interventions. Such knowledge will provide a strong scientific rationale for tailoring diet/ lifestyle interventions from a one-size-fits-all approach to a personalized approach. Attempts to integrate the emerging knowledge into personalized health practices are still in the very early stages.
Acknowledgment
Funding. Dr. Qi’s research is partly supported by the American Heart Association Scientist Development Award and the Boston Obesity Nutrition Research Center (DK46200).
Contributor Information
Lu Qi, Department of Nutrition, Harvard School of Public Health, and Channing Laboratory, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA..
Young Ae Cho, Channing Laboratory, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA..
REFERENCES
- 1.Ogden CL, Yanovski SZ, Carroll MD, et al. The epidemiology of obesity. Gastroenterology. 2007;132:2087–2102. doi: 10.1053/j.gastro.2007.03.052. [DOI] [PubMed] [Google Scholar]
- 2.Ogden CL, Flegal KM, Carroll MD, et al. Prevalence and trends in overweight among US children and adolescents, 1999–2000. JAMA. 2002;288:1728–1732. doi: 10.1001/jama.288.14.1728. [DOI] [PubMed] [Google Scholar]
- 3.Borecki IB, Higgins M, Schreiner PJ, et al. Evidence for multiple determinants of the body mass index: the National Heart, Lung, and Blood Institute Family Heart Study. Obes Res. 1998;6:107–114. doi: 10.1002/j.1550-8528.1998.tb00323.x. [DOI] [PubMed] [Google Scholar]
- 4.Bergstrom A, Pisani P, Tenet V, et al. Overweight as an avoidable cause of cancer. Eur Int J Cancer. 2001;91:421–430. doi: 10.1002/1097-0215(200002)9999:9999<::aid-ijc1053>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
- 5.Maes HH, Neale MC, Eaves LJ. Genetic and environmental factors in relative body weight and human adiposity. Behav Genet. 1997;27:325–351. doi: 10.1023/a:1025635913927. [DOI] [PubMed] [Google Scholar]
- 6.Stunkard AJ, Harris JR, Pedersen NL, et al. The body-mass index of twins who have been reared apart. N Engl J Med. 1990;322:1483–1487. doi: 10.1056/NEJM199005243222102. [DOI] [PubMed] [Google Scholar]
- 7.Sorensen TI. Genetic and environmental influences on obesity assessed by the adoption method. Rev Epidemiol Sante Publique. 1989;37:525–531. [PubMed] [Google Scholar]
- 8.Lander ES. The new genomics: global views of biology. Science. 1996;274:536–539. doi: 10.1126/science.274.5287.536. [DOI] [PubMed] [Google Scholar]
- 9.Loos RJ, Lindgren CM, Li S, et al. Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet. 2008;40:768–775. doi: 10.1038/ng.140. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Frayling TM, Timpson NJ, Weedon MN, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 2007;316:889–894. doi: 10.1126/science.1141634. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Qi L, Kang K, Zhang C, et al. FTO gene variant is associated with obesity: longitudinal analyses in two cohort studies and functional test. Diabetes. 2007;56:3075–3081. doi: 10.2337/db08-0006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Tan JT, Dorajoo R, Seielstad M, et al. FTO variants are associated with obesity in the Chinese and Malay populations in Singapore. Diabetes. 2008;57:2851–2857. doi: 10.2337/db08-0214. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Scuteri A, Sanna S, Chen WM, et al. Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet. 2007;3:e115. doi: 10.1371/journal.pgen.0030115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Yang W, Kelly T, He J. Genetic epidemiology of obesity. Epidemiol Rev. 2007;29:49–61. doi: 10.1093/epirev/mxm004. [DOI] [PubMed] [Google Scholar]
- 15.Lyon HN, Hirschhorn JN. Genetics of common forms of obesity: a brief overview. Am J Clin Nutr. 2005;82(Suppl):S215–S217. doi: 10.1093/ajcn/82.1.215S. [DOI] [PubMed] [Google Scholar]
- 16.Rankinen T, Zuberi A, Chagnon YC, et al. The human obesity gene map: the 2005 update. Obesity (Silver Spring) 2006;14:529–644. doi: 10.1038/oby.2006.71. [DOI] [PubMed] [Google Scholar]
- 17.Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science. 1996;273:1516–1517. doi: 10.1126/science.273.5281.1516. [DOI] [PubMed] [Google Scholar]
- 18.Dahlman I, Arner P. Obesity and polymorphisms in genes regulating human adipose tissue. Int J Obes (Lond) 2007;31:1629–1641. doi: 10.1038/sj.ijo.0803657. [DOI] [PubMed] [Google Scholar]
- 19.Benzinou M, Creemers JW, Choquet H, et al. Common nonsynonymous variants in PCSK1 confer risk of obesity. Nat Genet. 2008;40:943–945. doi: 10.1038/ng.177. [DOI] [PubMed] [Google Scholar]
- 20.Lohmueller KE, Pearce CL, Pike M, et al. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet. 2003;33:177–182. doi: 10.1038/ng1071. [DOI] [PubMed] [Google Scholar]
- 21.Qi L, Zhang C, van Dam RM, et al. Interleukin-6 genetic variability and adiposity: associations in two prospective cohorts and systematic review in 26,944 individuals. J Clin Endocrinol Metab. 2007;92:3618–3625. doi: 10.1210/jc.2007-0877. [DOI] [PubMed] [Google Scholar]
- 22.Paracchini V, Pedotti P, Taioli E. Genetics of leptin and obesity: a HuGE review. Am J Epidemiol. 2005;162:101–114. doi: 10.1093/aje/kwi174. [DOI] [PubMed] [Google Scholar]
- 23.Herbert A, Gerry NP, McQueen MB, et al. A common genetic variant is associated with adult and childhood obesity. Science. 2006;312:279–283. doi: 10.1126/science.1124779. [DOI] [PubMed] [Google Scholar]
- 24.Lyon HN, Emilsson V, Hinney A, et al. The association of a SNP upstream of INSIG2 with body mass index is reproduced in several but not all cohorts. PLoS Genet. 2007;3:e61. doi: 10.1371/journal.pgen.0030061. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Kuzuya M, Ando F, Iguchi A. No association between rs7566605 variant and being overweight in Japanese. Obesity (Silver Spring) 2007;15:2531–2534. doi: 10.1038/oby.2007.301. [DOI] [PubMed] [Google Scholar]
- 26.Dina C, Meyre D, Gallina S, et al. Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Genet. 2007;39:724–726. doi: 10.1038/ng2048. [DOI] [PubMed] [Google Scholar]
- 27.Li H, Wu Y, Loos RJ, et al. Variants in the fat mass- and obesityassociated (FTO) gene are not associated with obesity in a Chinese Han population. Diabetes. 2008;57:264–268. doi: 10.2337/db07-1130. [DOI] [PubMed] [Google Scholar]
- 28.Andreasen CH, Stender-Petersen KL, Mogensen MS, et al. Low physical activity accentuates the effect of the FTO rs9939609 polymorphism on body fat accumulation. Diabetes. 2008;57:95–101. doi: 10.2337/db07-0910. [DOI] [PubMed] [Google Scholar]
- 29.Loos RJ, Lindgren CM, Li S, et al. Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet. 2008;40:768–775. doi: 10.1038/ng.140. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Papas MA, Alberg AJ, Ewing R, et al. The built environment and obesity. Epidemiol Rev. 2007;29:129–143. doi: 10.1093/epirev/mxm009. [DOI] [PubMed] [Google Scholar]
- 31.Trends in intake of energy and macronutrients – United States, 1971–2000. MMWR Morb Mortal Wkly Rep. 2004;53:80–82. [PubMed] [Google Scholar]
- 32.Seidell JC. Dietary fat and obesity: an epidemiologic perspective. Am J Clin Nutr. 1998;67(Suppl):S546–S550. doi: 10.1093/ajcn/67.3.546S. [DOI] [PubMed] [Google Scholar]
- 33.Willett WC. Dietary fat plays a major role in obesity: no. Obes Rev. 2002;3:59–68. doi: 10.1046/j.1467-789x.2002.00060.x. [DOI] [PubMed] [Google Scholar]
- 34.Gross LS, Li L, Ford ES, et al. Increased consumption of refined carbohydrates and the epidemic of type 2 diabetes in the United States: an ecologic assessment. Am J Clin Nutr. 2004;79:774–779. doi: 10.1093/ajcn/79.5.774. [DOI] [PubMed] [Google Scholar]
- 35.Gardner CD, Kiazand A, Alhassan S, et al. Comparison of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women: the A TO Z Weight Loss Study: a randomized trial. JAMA. 2007;297:969–977. doi: 10.1001/jama.297.9.969. [DOI] [PubMed] [Google Scholar]
- 36.Astrup A, Raben A. Carbohydrate and obesity. Int J Obes Relat Metab Disord. 1995;19(Suppl 5):S27–S37. [PubMed] [Google Scholar]
- 37.Howarth NC, Saltzman E, Roberts SB. Dietary fiber and weight regulation. Nutr Rev. 2001;59:129–139. doi: 10.1111/j.1753-4887.2001.tb07001.x. [DOI] [PubMed] [Google Scholar]
- 38.Koh-Banerjee P, Franz M, Sampson L, et al. Changes in wholegrain, bran, and cereal fiber consumption in relation to 8-y weight gain among men. Am J Clin Nutr. 2004;80:1237–1245. doi: 10.1093/ajcn/80.5.1237. [DOI] [PubMed] [Google Scholar]
- 39.He K, Hu FB, Colditz GA, et al. Changes in intake of fruits and vegetables in relation to risk of obesity and weight gain among middle-aged women. Int J Obes Relat Metab Disord. 2004;28:1569–1574. doi: 10.1038/sj.ijo.0802795. [DOI] [PubMed] [Google Scholar]
- 40.Sabate J. Nut consumption and body weight. Am J Clin Nutr. 2003;78(Suppl):S647–S650. doi: 10.1093/ajcn/78.3.647S. [DOI] [PubMed] [Google Scholar]
- 41.Malik VS, Schulze MB, Hu FB. Intake of sugar-sweetened beverages and weight gain: a systematic review. Am J Clin Nutr. 2006;84:274–288. doi: 10.1093/ajcn/84.1.274. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Yeomans MR. Effects of alcohol on food and energy intake in human subjects: evidence for passive and active overconsumption of energy. Br J Nutr. 2004;92(Suppl 1):S31–S34. doi: 10.1079/bjn20041139. [DOI] [PubMed] [Google Scholar]
- 43.Williamson DF, Madans J, Pamuk E, et al. A prospective study of childbearing and 10-year weight gain in US white women 25 to 45 years of age. Int J Obes Relat Metab Disord. 1994;18:561–569. [PubMed] [Google Scholar]
- 44.Rissanen AM, Heliovaara M, Knekt P, et al. Determinants of weight gain and overweight in adult. Finn Eur J Clin Nutr. 1991;45:419–430. [PubMed] [Google Scholar]
- 45.Schoeller DA. Balancing energy expenditure and body weight. Am J Clin Nutr. 1998;68:S956–S961. doi: 10.1093/ajcn/68.4.956S. [DOI] [PubMed] [Google Scholar]
- 46.Burdette HL, Whitaker RC. A national study of neighborhood safety, outdoor play, television viewing, and obesity in preschool children. Pediatrics. 2005;116:657–662. doi: 10.1542/peds.2004-2443. [DOI] [PubMed] [Google Scholar]
- 47.Lev-Ran A. Human obesity: an evolutionary approach to understanding our bulging waistline. Diabetes Metab Res Rev. 2001;17:347–362. doi: 10.1002/dmrr.230. [DOI] [PubMed] [Google Scholar]
- 48.Neel JV. Diabetes mellitus: a “thrifty” genotype rendered detrimental by “progress”? Am J Hum Genet. 1962;14:353–362. [PMC free article] [PubMed] [Google Scholar]
- 49.Eaton SB, Konner M, Shostak M. Stone agers in the fast lane: chronic degenerative diseases in evolutionary perspective. Am J Med. 1988;84:739–749. doi: 10.1016/0002-9343(88)90113-1. [DOI] [PubMed] [Google Scholar]
- 50.Chakravarthy MV, Booth FW. Eating, exercise, and “thrifty” genotypes: connecting the dots toward an evolutionary understanding of modern chronic diseases. J Appl Physiol. 2004;96:3–10. doi: 10.1152/japplphysiol.00757.2003. [DOI] [PubMed] [Google Scholar]
- 51.Altshuler D, Hirschhorn JN, Klannemark M, et al. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet. 2000;26:76–80. doi: 10.1038/79216. [DOI] [PubMed] [Google Scholar]
- 52.Kaplan MS, Huguet N, Newsom JT, et al. The association between length of residence and obesity among Hispanic immigrants. Am J Prev Med. 2004;27:323–326. doi: 10.1016/j.amepre.2004.07.005. [DOI] [PubMed] [Google Scholar]
- 53.Ferreira SR, Lerario DD, Gimeno SG, et al. Obesity and central adiposity in Japanese immigrants: role of the Western dietary pattern. J Epidemiol. 2002;12:431–438. doi: 10.2188/jea.12.431. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Popkin BM. The nutrition transition and its health implications in lower-income countries. Public Health Nutr. 1998;1:5–21. doi: 10.1079/phn19980004. [DOI] [PubMed] [Google Scholar]
- 55.Hunter DJ. Gene-environment interactions in human diseases. Nat Rev Genet. 2005;6:287–298. doi: 10.1038/nrg1578. [DOI] [PubMed] [Google Scholar]
- 56.Rothman KJ. Epidemiology. An Introduction. New York: Oxford University Press; 2002. [Google Scholar]
- 57.Schmidt S, Schaid DJ. Potential misinterpretation of the caseonly study to assess gene-environment interaction. Am J Epidemiol. 1999;150:878–885. doi: 10.1093/oxfordjournals.aje.a010093. [DOI] [PubMed] [Google Scholar]
- 58.Manolio TA, Bailey-Wilson JE, et al. Genes, environment and the value of prospective cohort studies. Nat Rev Genet. 2006;7:812–820. doi: 10.1038/nrg1919. [DOI] [PubMed] [Google Scholar]
- 59.Miyaki K, Sutani S, Kikuchi H, et al. Increased risk of obesity resulting from the interaction between high energy intake and the Trp64Arg polymorphism of the beta3-adrenergic receptor gene in healthy Japanese men. J Epidemiol. 2005;15:203–210. doi: 10.2188/jea.15.203. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Song Y, Miyaki K, Araki J, et al. The interaction between the interleukin 6 receptor gene genotype and dietary energy intake on abdominal obesity in Japanese men. Metabolism. 2007;56:925–930. doi: 10.1016/j.metabol.2007.02.006. [DOI] [PubMed] [Google Scholar]
- 61.Robitaille J, Brouillette C, Houde A, et al. Association between the PPARalpha-L162V polymorphism and components of the metabolic syndrome. J Hum Genet. 2004;49:482–489. doi: 10.1007/s10038-004-0177-9. [DOI] [PubMed] [Google Scholar]
- 62.Nieters A, Becker N, Linseisen J. Polymorphisms in candidate obesity genes and their interaction with dietary intake of n-6 polyunsaturated fatty acids affect obesity risk in a subsample of the EPIC-Heidelberg cohort. Eur J Nutr. 2002;41:210–221. doi: 10.1007/s00394-002-0378-y. [DOI] [PubMed] [Google Scholar]
- 63.Memisoglu A, Hu FB, Hankinson SE, et al. Interaction between a peroxisome proliferator-activated receptor gamma gene polymorphism and dietary fat intake in relation to body mass. Hum Mol Genet. 2003;12:2923–2929. doi: 10.1093/hmg/ddg318. [DOI] [PubMed] [Google Scholar]
- 64.Luan J, Browne PO, Harding AH, et al. Evidence for genenutrient interaction at the PPARgamma locus. Diabetes. 2001;50:686–689. doi: 10.2337/diabetes.50.3.686. [DOI] [PubMed] [Google Scholar]
- 65.Robitaille J, Despres JP, Perusse L, et al. The PPAR-gamma P12A polymorphism modulates the relationship between dietary fat intake and components of the metabolic syndrome: results from the Quebec Family Study. Clin Genet. 2003;63:109–116. doi: 10.1034/j.1399-0004.2003.00026.x. [DOI] [PubMed] [Google Scholar]
- 66.Martinez JA, Corbalan MS, Sanchez-Villegas A, et al. Obesity risk is associated with carbohydrate intake in women carrying the Gln27Glu beta2-adrenoceptor polymorphism. J Nutr. 2003;133:2549–2554. doi: 10.1093/jn/133.8.2549. [DOI] [PubMed] [Google Scholar]
- 67.Marti A, Corbalan MS, Martinez-Gonzalez MA, et al. CHO intake alters obesity risk associated with Pro12Ala polymorphism of PPARgamma gene. J Physiol Biochem. 2002;58:219–220. doi: 10.1007/BF03179859. [DOI] [PubMed] [Google Scholar]
- 68.Meirhaeghe A, Helbecque N, Cottel D, et al. Beta2-adrenoceptor gene polymorphism, body weight, and physical activity. Lancet. 1999;353:896. doi: 10.1016/S0140-6736(99)00251-2. [DOI] [PubMed] [Google Scholar]
- 69.Corbalan MS, Marti A, Forga L, et al. The 27Glu polymorphism of the beta2-adrenergic receptor gene interacts with physical activity influencing obesity risk among female subjects. Clin Genet. 2002;61:305–307. doi: 10.1034/j.1399-0004.2002.610411.x. [DOI] [PubMed] [Google Scholar]
- 70.Moran CN, Vassilopoulos C, Tsiokanos A, et al. Effects of interaction between angiotensin I-converting enzyme polymorphisms and lifestyle on adiposity in adolescent Greeks. Obes Res. 2005;13:1499–1504. doi: 10.1038/oby.2005.181. [DOI] [PubMed] [Google Scholar]
- 71.Ridderstrale M, Johansson LE, Rastam L, et al. Increased risk of obesity associated with the variant allele of the PPARGC1A Gly482Ser polymorphism in physically inactive elderly men. Diabetologia. 2006;49:496–500. doi: 10.1007/s00125-005-0129-8. [DOI] [PubMed] [Google Scholar]
- 72.Alonso A, Marti A, Corbalan MS, et al. Association of UCP3 gene −55C > T polymorphism and obesity in a Spanish population. Ann Nutr Metab. 2005;49:183–188. doi: 10.1159/000086883. [DOI] [PubMed] [Google Scholar]
- 73.Berentzen T, Dalgaard LT, Petersen L, et al. Interactions between physical activity and variants of the genes encoding uncoupling proteins −2 and −3 in relation to body weight changes during a 10-y follow-up. Int J Obes (Lond) 2005;29:93–99. doi: 10.1038/sj.ijo.0802841. [DOI] [PubMed] [Google Scholar]
- 74.Shiwaku K, Nogi A, Anuurad E, et al. Difficulty in losing weight by behavioral intervention for women with Trp64Arg polymorphism of the beta3-adrenergic receptor gene. Int J Obes Relat Metab Disord. 2003;27:1028–1036. doi: 10.1038/sj.ijo.0802375. [DOI] [PubMed] [Google Scholar]
- 75.Yoshida T, Sakane N, Umekawa T, et al. Mutation of beta 3-adrenergic-receptor gene and response to treatment of obesity. Lancet. 1995;346:1433–1434. doi: 10.1016/s0140-6736(95)92452-3. [DOI] [PubMed] [Google Scholar]
- 76.Sakane N, Yoshida T, Umekawa T, et al. Effects of Trp64Arg mutation in the beta 3-adrenergic receptor gene on weight loss, body fat distribution, glycemic control, and insulin resistance in obese type 2 diabetic patients. Diabetes Care. 1997;20:1887–1890. doi: 10.2337/diacare.20.12.1887. [DOI] [PubMed] [Google Scholar]
- 77.Rawson ES, Nolan A, Silver K, et al. No effect of the Trp64Arg beta(3)-adrenoceptor gene variant on weight loss, body composition, or energy expenditure in obese, Caucasian postmenopausal women. Metabolism. 2002;51:801–805. doi: 10.1053/meta.2002.32781. [DOI] [PubMed] [Google Scholar]
- 78.Cha MH, Shin HD, Kim KS, et al. The effects of uncoupling protein 3 haplotypes on obesity phenotypes and very lowenergy diet-induced changes among overweight Korean female subjects. Metabolism. 2006;55:578–586. doi: 10.1016/j.metabol.2005.11.012. [DOI] [PubMed] [Google Scholar]
- 79.Shin HD, Kim KS, Cha MH, et al. The effects of UCP-1 polymorphisms on obesity phenotypes among Korean female subjects. Biochem Biophys Res Commun. 2005;335:624–630. doi: 10.1016/j.bbrc.2005.07.096. [DOI] [PubMed] [Google Scholar]
- 80.Yoon Y, Park BL, Cha MH, et al. Effects of genetic polymorphisms of UCP2 and UCP3 on very low calorie diet-induced body fat reduction in Korean female subjects. Biochem Biophys Res Commun. 2007;359:451–456. doi: 10.1016/j.bbrc.2007.05.110. [DOI] [PubMed] [Google Scholar]
- 81.Fumeron F, Durack-Bown I, Betoulle D, et al. Polymorphisms of uncoupling protein (UCP) and beta 3 adrenoreceptor genes in obese people submitted to a low calorie diet. Int J Obes Relat Metab Disord. 1996;20:1051–1054. [PubMed] [Google Scholar]
- 82.Kogure A, Yoshida T, Sakane N, et al. Synergic effect of polymorphisms in uncoupling protein 1 and beta3-adrenergic receptor genes on weight loss in obese Japanese. Diabetologia. 1998;41:1399. doi: 10.1007/s001250051084. [DOI] [PubMed] [Google Scholar]
- 83.Xinli W, Xiaomei T, Meihua P, et al. Association of a mutation in the beta3-adrenergic receptor gene with obesity and response to dietary intervention in Chinese children. Acta Paediatr. 2001;90:1233–1237. doi: 10.1080/080352501317130245. [DOI] [PubMed] [Google Scholar]
- 84.Mammes O, Betoulle D, Aubert R, et al. Novel polymorphisms in the 5′ region of the LEP gene: association with leptin levels and response to low-calorie diet in human obesity. Diabetes. 1998;47:487–489. doi: 10.2337/diabetes.47.3.487. [DOI] [PubMed] [Google Scholar]
- 85.Mammes O, Aubert R, Betoulle D, et al. LEPR gene polymorphisms: associations with overweight, fat mass and response to diet in women. Eur J Clin Invest. 2001;31:398–404. doi: 10.1046/j.1365-2362.2001.00843.x. [DOI] [PubMed] [Google Scholar]
- 86.Aberle J, Evans D, Beil FU, et al. A polymorphism in the apolipoprotein A5 gene is associated with weight loss after shortterm diet. Clin Genet. 2005;68:152–154. doi: 10.1111/j.1399-0004.2005.00463.x. [DOI] [PubMed] [Google Scholar]
- 87.Corella D, Qi L, Sorli JV, et al. Obese subjects carrying the 11482G > A polymorphism at the perilipin locus are resistant to weight loss after dietary energy restriction. J Clin Endocrinol Metab. 2005;90:5121–5126. doi: 10.1210/jc.2005-0576. [DOI] [PubMed] [Google Scholar]
- 88.de Luis DA, Aller R, Izaola O, et al. Influence of ALA54THR polymorphism of fatty acid binding protein 2 on lifestyle modification response in obese subjects. Ann Nutr Metab. 2006;50:354–360. doi: 10.1159/000094299. [DOI] [PubMed] [Google Scholar]
- 89.Goyenechea E, Dolores Parra M, et al. Weight regain after slimming induced by an energy-restricted diet depends on interleukin-6 and peroxisome-proliferator-activatedreceptor-gamma2 gene polymorphisms. Br J Nutr. 2006;96:965–972. doi: 10.1017/bjn20061901. [DOI] [PubMed] [Google Scholar]
- 90.Santoro N, Perrone L, Cirillo G, et al. Effect of the melanocortin-3 receptor C17A and G241A variants on weight loss in childhood obesity. Am J Clin Nutr. 2007;85:950–953. doi: 10.1093/ajcn/85.4.950. [DOI] [PubMed] [Google Scholar]
- 91.Ordovas JM, Mooser V. Nutrigenomics and nutrigenetics. Curr Opin Lipidol. 2004;15:101–108. doi: 10.1097/00041433-200404000-00002. [DOI] [PubMed] [Google Scholar]
- 92.Kaput J, Perlina A, Hatipoglu B, et al. Nutrigenomics: concepts and applications to pharmacogenomics and clinical medicine. Pharmacogenomics. 2007;8:369–390. doi: 10.2217/14622416.8.4.369. [DOI] [PubMed] [Google Scholar]